✦ LIBER ✦

PCV58 CLINICAL AND ECONOMIC ISSUES IN THE PREVENTION OF VENOUS THROMBOEMBOLISM IN HOSPITALIZED ORTHOPEDIC PATIENTS: ENOXAPARIN VERSUS WARFARIN

✍ Scribed by S Balu; FR Vogenberg; L Lichtig; P O'Connor

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Economic evaluation of enoxaparin for th

✍ Offord, Robin ;Lloyd, Adam C. ;Anderson, Pippa ;Bearne, Andy 📂 Article 📅 2004 🏛 Springer 🌐 Dutch ⚖ 123 KB

PCV35 PHARMACOECONOMIC MODEL OF ENOXAPAR

✍ R Milani-Jr; W Follador; J Gonçalves; V Di Sena 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

PCV62 CLINICAL AND ECONOMIC OUTCOMES OF

✍ J Slof; S Magaz; X Badia 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Prevention of venous thromboembolism in

✍ Duff, Jed; Walker, Kim; Omari, Abdullah; Stratton, Charlie 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Clinical and economic consequences of us

✍ Milani, R.; Barbosa, E.G.; Penha, M.; Machado, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCV19 COST-EFFECTIVENESS OF RIVAROXABAN

✍ Chen, XB; Eggington, S; Wang, CY; Zhu, M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB